Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06486428 · ClinicalTrials.gov registry record
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
A clinical trial of Small-cell Lung Cancer, sponsored by Addario Lung Cancer Medical Institute.
- Recruiting
- Registry status
- 30
- Enrollment target
- 20
- Study locations
NCT06486428 is a study of Small-cell Lung Cancer that is actively recruiting participants, run by Addario Lung Cancer Medical Institute. The registered enrollment target is 30 participants, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 20 states.
The verdict
NCT06486428, a study of Small-cell Lung Cancer, is actively recruiting participants, sponsored by Addario Lung Cancer Medical Institute.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.
Conditions Studied
Study Locations (20)
Alabama
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
Alaska
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
Arizona
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
Arkansas
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
California
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
Colorado
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
Connecticut
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
Delaware
- Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html - Multiple Locations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-23 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06486428
The ClinicalTrials.gov registry entry for NCT06486428 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Addario Lung Cancer Medical Institute, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Small-cell Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06486428 reports 20 study locations spanning 20 distinct geographic areas - top geographies include Alabama, Alaska, Arizona.
Frequently Asked Questions
What is clinical trial NCT06486428 about?
NCT06486428 is a clinical study titled "Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies". This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, reg...
What is the current status of trial NCT06486428?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-05-23. Estimated completion is 2027-06.
What conditions does trial NCT06486428 study?
This clinical trial studies the following conditions: Small-cell Lung Cancer.
Who is sponsoring clinical trial NCT06486428?
This trial is sponsored by Addario Lung Cancer Medical Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06486428 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Small-cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RECRUITING · Phase 1
-
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RECRUITING · Phase 3
-
7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
RECRUITING
-
A Study of Hospital-at-Home for People Receiving Tarlatamab
RECRUITING · NA
-
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
RECRUITING · Phase 3
-
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.